PMID: 6971526Jan 1, 1981Paper

Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with bleeding disorders

Vox Sanguinis
N Anh-TuanS R Hollán

Abstract

Approximately 90% of 67 multi-transfused patients with bleeding disorders were positive either for anti-HBs (85%) or HBsAg (45%). Using a polyethylene glycol trypsinization assay, we found anti-HbsAg-containing specific circulating immune complexes (HBsAg-CICs) in 3 of the 57 HBsAg-negative haemophiliacs possessing anti-HBs. The occurrence of HBsAg-CICs may be a regular event in the conversion phase of HBs infection. Circulating immune complexes as detected by the anticomplementary assay were found in 32 of the 67 (48%) patients.

Citations

Oct 19, 1992·Journal of Immunological Methods·T MaruyamaD R Milich
May 3, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Simon BredlSusanne Modrow
Jan 1, 1992·Transfusion Medicine Reviews·E D GompertsR De Vreker
Nov 1, 1983·The Journal of Pediatrics·P S WeintrubA J Ammann
Aug 1, 2014·PLoS Computational Biology·Stanca M CiupeAlan S Perelson
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·K Hoots, D Canty
Aug 22, 2018·Immunological Reviews·Stanca M Ciupe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.